Cytek Biosciences, Inc. CTKB Operating Lease Liabilities (Total)
Operating Lease Liabilities (Total) at other companies
Other financials
Where this comes from
Reported directly by Cytek Biosciences, Inc. in its filing.
Tagged under the XBRL concept us-gaap:OperatingLeaseLiability.
The official record: Cytek Biosciences, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Cytek Biosciences, Inc.'s operating lease liabilities (total).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Cytek Biosciences, Inc.'s operating lease liabilities (total)?
- Cytek Biosciences, Inc. (CTKB) reported operating lease liabilities (total) of $16.39M in Q1 2026.
- How has Cytek Biosciences, Inc.'s operating lease liabilities (total) changed year-over-year?
- Cytek Biosciences, Inc.'s operating lease liabilities (total) increased by 49.1% year-over-year, from $10.99M to $16.39M.
- What is the long-term trend for Cytek Biosciences, Inc.'s operating lease liabilities (total)?
- Over 4 years (2021 to 2025), Cytek Biosciences, Inc.'s operating lease liabilities (total) has grown at a 2.7% compound annual growth rate (CAGR), from $15.2M to $16.92M.
- What does operating lease liabilities (total) mean?
- This represents the total present value of future lease payments for operating leases, recognized as a liability on the balance sheet. It reflects the company's long-term commitment to leased assets such as office space, warehouses, and equipment. Tracking this helps investors evaluate the company's off-balance-sheet financing obligations and overall debt-like commitments.